Balyasny Asset Management’s Amicus Therapeutics FOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.42M Sell
421,815
-481,419
-53% -$2.76M ﹤0.01% 1107
2025
Q1
$7.37M Buy
903,234
+53,829
+6% +$439K 0.01% 755
2024
Q4
$8M Sell
849,405
-1,065,578
-56% -$10M 0.01% 728
2024
Q3
$20.5M Buy
1,914,983
+797,883
+71% +$8.52M 0.03% 448
2024
Q2
$11.1M Buy
+1,117,100
New +$11.1M 0.02% 608
2024
Q1
Sell
-1,556,540
Closed -$22.1M 2135
2023
Q4
$22.1M Sell
1,556,540
-1,828,892
-54% -$26M 0.04% 420
2023
Q3
$41.2M Buy
3,385,432
+160,399
+5% +$1.95M 0.08% 257
2023
Q2
$40.5M Buy
3,225,033
+1,106,425
+52% +$13.9M 0.09% 258
2023
Q1
$23.5M Buy
2,118,608
+118,752
+6% +$1.32M 0.06% 364
2022
Q4
$24.4M Buy
1,999,856
+314,888
+19% +$3.84M 0.07% 324
2022
Q3
$17.6M Sell
1,684,968
-468,116
-22% -$4.89M 0.05% 387
2022
Q2
$23.1M Buy
+2,153,084
New +$23.1M 0.08% 302
2021
Q2
Sell
-13,468
Closed -$133K 1800
2021
Q1
$133K Buy
+13,468
New +$133K ﹤0.01% 1427
2020
Q4
Sell
-22,984
Closed -$325K 1271
2020
Q3
$325K Buy
+22,984
New +$325K ﹤0.01% 937
2017
Q4
Sell
-12,900
Closed -$195K 1857
2017
Q3
$195K Sell
12,900
-212,414
-94% -$3.21M ﹤0.01% 1507
2017
Q2
$2.27M Buy
+225,314
New +$2.27M 0.01% 739
2016
Q3
Sell
-300,000
Closed -$1.64M 969
2016
Q2
$1.64M Buy
300,000
+109,956
+58% +$600K 0.01% 543
2016
Q1
$1.61M Buy
+190,044
New +$1.61M 0.01% 539
2015
Q2
Sell
-1,436,694
Closed -$15.6M 968
2015
Q1
$15.6M Sell
1,436,694
-48,115
-3% -$523K 0.13% 210
2014
Q4
$12.4M Buy
+1,484,809
New +$12.4M 0.11% 209
2014
Q2
Sell
-194,163
Closed -$402K 477
2014
Q1
$402K Sell
194,163
-318,121
-62% -$659K ﹤0.01% 396
2013
Q4
$1.2M Buy
512,284
+25,499
+5% +$59.9K 0.02% 334
2013
Q3
$1.13M Buy
486,785
+86,785
+22% +$201K 0.02% 377
2013
Q2
$932K Buy
+400,000
New +$932K 0.02% 367